Stonepine Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Stonepine Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell
2020 Q2	$147K	Buy
2018 Q1	–	Sell
2017 Q4	$1.24M	Buy